Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies
CD19联合CD22或CD20嵌合抗原受体T细胞疗法治疗血液系统恶性肿瘤的疗效和安全性
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1577360
Yuan, Xiaoshuang; Wang, Feiqing; Zhao, Peng; Yang, Bo; Yang, Xu; Tian, Ting; Li, Bingbing; Liu, Guangyang; Wang, Sanbin; Tang, Dongxin; He, Zhixu; Li, Yanju; Liu, Yang
肿瘤
T细胞
肿瘤免疫
信号转导
CD22
CD20
T细胞
细胞生物学
CD2
CD19
免疫/内分泌